An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy is a research paper published in The Journal of Experimental Medicine (2021). On theSindex it has a DataRank of 0.698. It has been cited 104 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.698
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: CA109182
National Cancer Institute
Grant: CA216248
National Cancer Institute
Grant: CA218024
National Cancer Institute
Grant: CA196521
National Cancer Institute
Grant: CA201054
Susan G. Komen
Grant: CCR17483357
Melanoma Research Alliance
Grant: 401181
National Cancer Institute
Grant: CA078207
Portuguese Foundation for Science and Technology
Grant: SFRH/BD/100380/2014
Deutsche Krebshilfe
Grant: 109600
National Institutes of Health
Grant: S10OD018522
National Institutes of Health
Grant: S10OD026880
NCI NIH HHS
Grant: P30 CA196521
NCI NIH HHS
Grant: R01 CA216248
NCI NIH HHS
Grant: R01 CA218024
NCI NIH HHS
Grant: R01 CA109182
NCI NIH HHS
Grant: T32 CA078207
NCI NIH HHS
Grant: K22 CA201054
Samuel Waxman Cancer Research Foundation
National Institutes of Health
BioAccelerate NYC–NYC Partnership Fund
HiberCell
FWCI
5.03
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals